Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms

Molecular and Cellular Biology

Volumn 31, Issue 3, 2011, Pages 450-457

  Cho, Kae Won ^a   Zhou, Yingjiang ^a   Sheng, Liang ^a   Rui, Liangyou ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN SENSITIZING AGENT; LIPOCALIN; LIPOCALIN 13; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TYPE; DRUG ACTIVITY; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INSULIN DEPENDENCE; LIVER CELL CULTURE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADENOVIRIDAE; ADIPOCYTES; ANIMALS; DIABETES MELLITUS, TYPE 2; DIETARY FATS; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; LIPOCALINS; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; SIGNAL TRANSDUCTION;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 78751499277     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00459-10     Document Type: Article

References (26)

1. Ahima, R. S., and S. Y. Osei. 2008. Adipokines in obesity. Front. Horm. Res. 36:182-197.
2. Brennan, P. A., and K. M. Kendrick. 2006. Mammalian social odours: attraction and individual recognition. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361:2061-2078.
3. Chamero, P., et al. 2007. Identification of protein pheromones that promote aggressive behaviour. Nature 450:899-902. (Pubitemid 350231315)
4. Erion, D. M., and G. I. Shulman. 2010. Diacylglycerol-mediated insulin resistance. Nat. Med. 16:400-402.
5. Graham, T. E., et al. 2006. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 354:2552-2563.
6. Halberg, N., I. Wernstedt-Asterholm, and P. E. Scherer. 2008. The adipocyte as an endocrine cell. Endocrinol. Metab. Clin. North Am. 37:753-768.
7. Hotamisligil, G. S. 2006. Inflammation and metabolic disorders. Nature 444:860-867.
8. Hui, X., et al. 2009. Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice. J. Biol. Chem. 284:14050-14057.
9. Kloting, N., et al. 2007. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab. 6:79-87. (Pubitemid 46995778)
10. Law, I. K., et al. 2010. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 59:872-882.
11. Liu, L., et al. 2007. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J. Clin. Invest. 117:1679-1689.
12. More, L. 2006. Mouse major urinary proteins trigger ovulation via the vomeronasal organ. Chem. Senses 31:393-401. (Pubitemid 43978550)
13. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
14. Postic, C., R. Dentin, and J. Girard. 2004. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 30:398-408. (Pubitemid 39648006)
15. Rui, L., M. Yuan, D. Frantz, S. Shoelson, and M. F. White. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277:42394-42398.
16. Saltiel, A. R., and C. R. Kahn. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806.
17. Schenk, S., and J. F. Horowitz. 2007. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J. Clin. Invest. 117:1690-1698.
18. Schlehuber, S., and A. Skerra. 2005. Lipocalins in drug discovery: from natural ligand-binding proteins to "anticalins." Drug Discov. Today 10:23-33.
19. Shoelson, S. E., and A. B. Goldfine. 2009. Getting away from glucose: fanning the flames of obesity-induced inflammation. Nat. Med. 15:373-374.
20. Suzuki, K., et al. 2004. Molecular evolution of epididymal lipocalin genes localized on mouse chromosome 2. Gene 339:49-59. (Pubitemid 39201127)
21. Tarantino, G., G. Saldalamacchia, P. Conca, and A. Arena. 2007. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J. Gastroenterol. Hepatol. 22:293-303.
22. Taube, A., K. Eckardt, and J. Eckel. 2009. Role of lipid-derived mediators in skeletal muscle insulin resistance. Am. J. Physiol. Endocrinol. Metab. 297:1004-1012.
23. Yan, Q. W., et al. 2007. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56:2533-2540.
24. Yang, Q., et al. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356-362. (Pubitemid 41065039)
25. Zhou, Y., L. Jiang, and L. Rui. 2009. Identification of MUP1 as a regulator for glucose and lipid metabolism in mice. J. Biol. Chem. 284:11152-11159.
26. Zhou, Y., and L. Rui. 2010. Major urinary protein regulation of chemical communication and nutrient metabolism. Vitam. Horm. 83:151-163.